Table 1.
Descriptive measure.
| Category | Severity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| No. of BCCs | 1 BCC | 2 BCCs | 3 BCCs | 4 BCCs | 5 BCCs | 7 BCCs | 10 BCCs | ||
| No. of patients | 159 | 35 | 15 | 7 | 3 | 1 | 2 | ||
| (71.60%) | (15.77%) | (6.76%) | (3.15%) | (1.35%) | (0.45%) | (0.90%) | |||
| Time between first and further diagnoses | 50.82% of the patients | ||||||||
| Same time | |||||||||
| Sex | Male* | ||||||||
| 128 (57.66%) | |||||||||
| Age of diagnosis | Ø 72.59 y | ||||||||
| SD=10.90 y | |||||||||
| Size | Ø 0.85 cm | ||||||||
| SD=0.89 cm | |||||||||
| Localization | Nose* | Temple | Eye | Ear | Frontal | Cheek | Lips | Cervikal | Rest |
| 86 | 50 | 50 | 49 | 44 | 33 | 9 | 9 | 4 | |
| (25.2%) | (14.5%) | (14.5%) | (14.2%) | (12.8%) | (9.8%) | (2.6%) | (2.6%) | ||
| Histology | Nodular* | Superficial | Morpheaform | Nodular, | Nodular, | Nodular, | Rest | ||
| 152 | 50 | 24 | morpheaform | superficial | ulcerated | 35 | |||
| (46.3%) | (15.2%) | (7.3%) | 13 | 28 | 26 | ||||
| Adjacent tissue | (4.0%) | (8.5%) | (7.9%) | ||||||
| Normal skin | Adjacent elastosis or keratosis | ||||||||
| 158 (45,9%) | 186 (54,1%) | ||||||||
| Further malignancies | 51 patients with further 78 malignancies | ||||||||
| 28 patients had 45 SCCs | |||||||||
| 6 patients had 6 MMs | |||||||||
| Operated precancerous | Patients: 81 | Lesions: 173 | |||||||
| lesions | Elastosis: 60 | ||||||||
| Keratosis: 81 |
BCC, basal cell carcinoma; SCC, Squamous cell carcinoma; MM, Malignant melanoma.
*P>0.05 in the binominal test.